Nothing Special   »   [go: up one dir, main page]

ES2064661T3 - 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa. - Google Patents

11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa.

Info

Publication number
ES2064661T3
ES2064661T3 ES90311807T ES90311807T ES2064661T3 ES 2064661 T3 ES2064661 T3 ES 2064661T3 ES 90311807 T ES90311807 T ES 90311807T ES 90311807 T ES90311807 T ES 90311807T ES 2064661 T3 ES2064661 T3 ES 2064661T3
Authority
ES
Spain
Prior art keywords
alpha
dieno
ceto
steroids
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90311807T
Other languages
English (en)
Inventor
Dennis Alan Holt
Brian Walter Metcalf
Mark Alan Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2064661T3 publication Critical patent/ES2064661T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/002—Expansion of ring A by one atom, e.g. A homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPUESTOS DE LA ESTRUCTURA: EN LA QUE X ES CETO O H Y OH; R ELEVADO 1 ES H O C SUB 1-8 ALCALI; R (AL CUADRADO) ES (1) A-H, (ALFA)-ACETOXI Y/O (BETA)-WCOR ELEVADO 3 DONDE W ES UNA UNION O C SUB 1-12 ALCALI Y R ELEVADO 3 ES C SUB 1-8 ALCALI, C SUB 1-8 ALKOXI DE N(R ELEVADO 4) 2 DONDE R ELEVADO 4 ES INTER ALIA, H O C SUB 1-8 ALCALI; (2) = CHWCOR ELEVADO 3 O = CHWOR ELEVADO 5 DONDE W Y R ELEVADO 3 SON COMO ARRIBA Y R ELEVADO 5 ES INTER ALIA, FENILALKILCARBONIL, BENZOIL, ALKOXICARBONIL, AMINOCARBONIL, ALKIL O ALKILCARBONIL; (3) (ALFA)-H Y (BETA)-NHCOR ELEVADO 6 DONDE R ELEVADO 6 ES ALCALI O (BETA)-N(R ELEVADO 4) SUB 2 O (4) CETO, PROCEDIMIENTOS PARA SU PREPARACION, COMPUESTOS FARMACEUTICOS QUE LOS CONTIENEN Y SU UTILIZACION EN TERAPIAS COMO INHIBIDORES DE 5-(ALFA)-REDUCTASA.
ES90311807T 1989-11-01 1990-10-29 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa. Expired - Lifetime ES2064661T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/430,152 US5041433A (en) 1987-04-29 1989-11-01 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase

Publications (1)

Publication Number Publication Date
ES2064661T3 true ES2064661T3 (es) 1995-02-01

Family

ID=23706275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90311807T Expired - Lifetime ES2064661T3 (es) 1989-11-01 1990-10-29 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa.

Country Status (15)

Country Link
US (1) US5041433A (es)
EP (1) EP0427434B1 (es)
JP (1) JPH03169890A (es)
KR (1) KR100187945B1 (es)
AT (1) ATE115587T1 (es)
AU (1) AU641701B2 (es)
CA (1) CA2028622A1 (es)
DE (1) DE69015129T2 (es)
DK (1) DK0427434T3 (es)
ES (1) ES2064661T3 (es)
GR (1) GR3015372T3 (es)
IE (1) IE65562B1 (es)
NZ (1) NZ235871A (es)
PT (1) PT95750A (es)
ZA (1) ZA908730B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516768A (en) * 1990-03-16 1996-05-14 Smithkline Beecham Corporation Uncompetitive inhibition of steroid and 5α-reductose
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
NZ245504A (en) * 1991-12-20 1995-08-28 Hoechst Ag Bile acid derivatives containing an ethylenically unsaturated grouping
US5215894A (en) * 1992-02-25 1993-06-01 Merck & Co., Inc. Biological process for producing 17β-N-monosubstituted carbamoyl-11-oxo-4-aza-5-α-androst-3-one testosterone-5-α reductase inhibitors
EP0641211A1 (en) * 1992-05-21 1995-03-08 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5$g(a)-REDUCTASE ACTIVITY
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
AP9300589A0 (en) * 1992-11-18 1994-01-31 Smithkline Beecham Corp Novel 17a and 17b substituted acyl-3-carboxy 3,5-diene steroidal compounds, pharmaceutical compositions containing these compounds, and methods for using these compounds to inhibit steroid 5-a-reductase.
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5637310A (en) * 1993-12-20 1997-06-10 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20060148725A1 (en) * 2001-12-21 2006-07-06 The Miriam Hospital Selective 11beta HSD inhibitors and methods of use thereof
EP1587574A4 (en) * 2001-12-21 2009-03-18 Rhode Island Hospital 11b-HSD SELECTIVE INHIBITORS AND METHODS OF USE
US20050020550A1 (en) * 2003-04-29 2005-01-27 Morris David J. Selective testicular 11beta-HSD inhibitors and methods of use thereof
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
CN104208718B (zh) 2009-02-20 2017-12-29 2-Bbb医疗股份有限公司 基于谷胱甘肽的药物递送系统
MY163048A (en) 2009-05-06 2017-08-15 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191759A (en) * 1978-04-13 1980-03-04 Merck & Co., Inc. N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
DK465481A (da) * 1980-11-21 1982-05-22 Hoffmann La Roche Fremgangsmaade til fremstilling af d-homostemoider
US4814324A (en) * 1987-03-06 1989-03-21 Merck & Co., Inc. Sterol inhibitors of testosterone 5α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors

Also Published As

Publication number Publication date
AU641701B2 (en) 1993-09-30
IE65562B1 (en) 1995-11-01
CA2028622A1 (en) 1991-05-02
EP0427434A2 (en) 1991-05-15
AU6551190A (en) 1991-07-18
US5041433A (en) 1991-08-20
EP0427434A3 (en) 1992-03-04
IE903920A1 (en) 1991-05-08
NZ235871A (en) 1991-12-23
PT95750A (pt) 1991-09-13
ATE115587T1 (de) 1994-12-15
DE69015129D1 (de) 1995-01-26
JPH03169890A (ja) 1991-07-23
EP0427434B1 (en) 1994-12-14
ZA908730B (en) 1991-11-27
DE69015129T2 (de) 1995-05-04
GR3015372T3 (en) 1995-06-30
KR910009725A (ko) 1991-06-28
KR100187945B1 (ko) 1999-06-01
DK0427434T3 (da) 1995-05-08

Similar Documents

Publication Publication Date Title
ES2064661T3 (es) 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa.
EP0613883A4 (en) HYDROXAMIC ACID DERIVATIVE.
PT80157B (en) Methods of treating viral diseases with pyridazinamines anti-virally active pyridazinamines
HUT67285A (en) Cyclic ureas and analogues and pharmaceutical compositions
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
PT727419E (pt) Compostos intermediarios para a preparacao de inibidores da protease retroviral
ES2123654T3 (es) Carbapenems que contienen un grupo fenilo substituido con carboxi, procesos para su preparacion, productos intermedios y uso como antibioticos.
TW268005B (es)
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
ZA911728B (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
FI935777A0 (fi) Inhibitorer foer HIV-proteas anvaendbara vid behandling av AIDS
PT100583A (pt) Metodo de tratamento e/ou profilaxia utilizando,por exemplo, derivados de benzopirano, composicoes que os contem, compostos utilizados e processos para a sua preparacao
EP0199400A3 (en) Substituted n-û(4-piperidinyl)alkyl¨ bicyclic condensed ozazol- and thiazolamines
ES2074462T3 (es) Derivados 3-piperazinil-benzazoles antipsicoticos.
NZ218170A (en) Piperidine derivatives and pharmaceutical compositions
ATE92960T1 (de) Alpha-1-antitrypsin-varianten, besonders verwendbar als kallikrein-inhibitoren.
GR3031095T3 (en) 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION.
ES2000681A6 (es) Un procedimiento para preparar nuevos compuestos de bencilpiperazina
FI923662A (fi) Terapeutiska medel
ZA906666B (en) 3-substituted nitro-steroid derivatives as 5-alpha-reductase inhibitors
ZA911994B (en) Novel ascorbic acid derivatives
HUT54688A (en) Process for producing compounds utilizable for treating ulcus and pharmaceutical compositions containing them as active components
AR241434A1 (es) Procedimiento para la preparacion de 3-(piperidinil)-1h-indazoles.
EP0653207A4 (en) AIDS VIRUS INFECTIVE COMPOSITION.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 427434

Country of ref document: ES